Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis (Q39557202)
Jump to navigation
Jump to search
scientific article published on August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis |
scientific article published on August 2011 |
Statements
1 reference
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis (English)
1 reference
Victoria Makovski
1 reference
Roni Haklai
1 reference
Yoel Kloog
1 reference
1 August 2011
1 reference
1 reference
130
1 reference
6
1 reference
1420-1429
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference